V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001622 | 230001055 | 1.59 | 61.1 | Adjuvant (A) | 2018-12-24 | 2018-12-24 | Trastuzumab 21 day maintenance | N | N | 230004040 | IFOSFAMIDE |
| 230001623 | 230000626 | 1.75 | 67.2 | Adjuvant (A) | 2016-12-23 | 2017-01-19 | Ipilimumab | null | N | 230014751 | CAPECITABINE + OXALIPLATIN |
| 230001624 | 230000629 | 1.49 | 65.5 | Palliative (P) | 2019-07-02 | 2019-07-03 | CARBOPLATIN | 02 | N | 230014868 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 230001625 | 230000632 | 1.49 | null | Palliative (P) | 2019-02-01 | 2019-02-06 | Trastuzumab Subcutaneous | 02 | N | 230015009 | CAPECITABINE + OXALIPLATIN |
| 230001626 | 230000635 | 0 | null | Palliative (P) | 2016-06-28 | 2016-07-14 | TRASTUZUMAB | N | N | 230015520 | OXALIPLATIN + MDG |
| 230001627 | 230000641 | null | null | Palliative (P) | 2018-04-26 | 2018-06-23 | FLUOROURACIL + OXALIPLATIN | N | null | 230016636 | IVA |
| 230001628 | 230000642 | 1.68 | null | Palliative (P) | 2016-09-09 | 2016-09-10 | AFLIBERCEPT + FU + IRINOTECAN | 02 | null | 230016762 | IRINOTECAN + MDG |
| 230001629 | 230000643 | 1.79 | 69 | Curative (C) | 2017-12-04 | 2017-12-13 | Ipilimumab | N | N | 230016815 | FLUOROURACIL |
| 230001630 | 230001296 | 1.63 | 92.9 | Curative (C) | 2018-08-20 | 2018-09-04 | Capecitabine | 02 | N | 230018347 | CVD |
| 230001631 | 230000650 | 1.8 | 89.2 | Palliative (P) | 2016-11-30 | 2016-11-09 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 230018767 | CAPECITABINE |
| 230001632 | 230000654 | 1.64 | 73.7 | Palliative (P) | 2014-03-06 | 2014-06-30 | LEAM | N | N | 230019077 | CETUXIMAB + IRINOTECAN + MDG |
| 230001633 | 230000660 | null | 54.2 | Palliative (P) | 2017-11-16 | 2017-11-17 | Cisplatin | 2 | null | 230020093 | AFLIBERCEPT + FU + IRINOTECAN |
| 230001634 | 230000663 | 1.76 | 105.5 | Palliative (P) | 2013-11-18 | 2013-11-18 | R GCVP | N | N | 230020870 | CAPECITABINE |
| 230001635 | 230000666 | 1.68 | 59.6 | Palliative (P) | 2014-11-08 | 2016-09-18 | Oxaliplatin + Modified de Gramont | N | N | 230021348 | BEVACIZUMAB |
| 230001636 | 230000675 | 1.68 | null | Palliative (P) | 2019-08-07 | 2019-08-20 | Capecitabine + Oxaliplatin 21day | N | N | 230022180 | AFLIBERCEPT + FU + IRINOTECAN |
| 230001637 | 230000680 | 1.75 | 89 | Palliative (P) | 2015-04-05 | 2016-06-09 | Oxaliplatin + Modified de Gramont | N | null | 230022891 | FLUOROURACIL |
| 230001638 | 230000683 | 1.49 | 50.8 | Palliative (P) | 2013-12-25 | 2014-01-08 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 230023028 | OXALIPLATIN + MDG |
| 230001639 | 230000685 | 1.66 | null | Palliative (P) | 2017-03-13 | 2017-04-11 | Capecitabine + Oxaliplatin 21day | N | N | 230023028 | FLUOROURACIL |
| 230001640 | 230000689 | 1.64 | 62.2 | Palliative (P) | 2018-02-12 | 2018-03-10 | Oxaliplatin + Modified de Gramont | N | N | 230024143 | CAPECITABINE + OXALIPLATIN |
| 230001641 | 230000694 | 166.5 | 94.3 | Palliative (P) | null | 2014-12-11 | EVEROLIMUS | 02 | N | 230024456 | OXALIPLATIN + MDG + PANITUMUMAB |
| 230001642 | 230001315 | 1.84 | 82.8 | Not known (9) | 2016-12-18 | 2017-11-07 | R GCVP | 02 | N | 230024684 | FLUOROURACIL |
| 230001643 | 230000700 | 1.7 | 109 | Adjuvant (A) | 2017-10-15 | 2017-10-16 | CETUXIMAB + IRINOTECAN + MDG | null | N | 230024788 | OXALIPLATIN + MDG |
| 230001644 | 230000704 | 1.82 | 93.7 | Palliative (P) | null | 2018-01-17 | Trial Unspecified | N | null | 230025421 | CAPECITABINE + OXALIPLATIN |
| 230001645 | 230000707 | 1.63 | null | Palliative (P) | 2019-08-31 | 2019-08-31 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 230025748 | CETUXIMAB + IRINOTECAN + MDG |
| 230001646 | 230001317 | 1.8 | 92.8 | Palliative (P) | 2016-09-24 | 2017-02-10 | ICE-R (Cycle 2 onwards) | N | N | 230025830 | CETUXIMAB + IRINOTECAN + MDG |
| 230001647 | 230000713 | 1.54 | null | Palliative (P) | 2017-05-20 | 2017-05-20 | Oxaliplatin + Modified de Gramont | 02 | N | 230026262 | OXALIPLATIN + MDG |
| 230001648 | 230000719 | 1.62 | 57.2 | Palliative (P) | 2013-04-09 | 2013-04-09 | Trifluridine + Tipiracil | 2 | N | 230026784 | IRINOTECAN + MDG |
| 230001649 | 230000720 | 1.54 | 70.5 | Not known (9) | 2015-12-15 | 2016-01-27 | Oxaliplatin + Modified de Gramont | N | N | 230026784 | FLUOROURACIL |
| 230001650 | 230000727 | null | null | Adjuvant (A) | 2015-10-19 | 2015-10-31 | Irinotecan + Modified De Gramont | 2 | null | 230000028 | NOT MATCHED |
| 230001651 | 230000729 | 1.59 | null | Palliative (P) | 2016-12-29 | 2016-12-30 | TRASTUZUMAB | 2 | N | 230000042 | FLUOROURACIL |
| 230001652 | 230001332 | 1.79 | 95.1 | Curative (C) | 2015-04-12 | 2015-04-12 | EVEROLIMUS | 2 | N | 230000436 | CAPECITABINE |
| 230001653 | 230000745 | 1.64 | 80 | Palliative (P) | 2014-08-03 | 2014-08-03 | Oxaliplatin + Modified de Gramont | 02 | N | 230000898 | AFLIBERCEPT + FU + IRINOTECAN |
| 230001654 | 230000751 | 1.77 | null | Adjuvant (A) | 2015-10-12 | 2016-07-14 | Capecitabine + Oxaliplatin 21day | 02 | N | 230000981 | CAPECITABINE |
| 230001655 | 230000761 | null | 84 | Palliative (P) | 2016-05-29 | 2016-06-25 | Sorafenib | N | Y | 230001490 | OXALIPLATIN + MDG |
| 230001656 | 230001579 | 1.72 | 67.2 | Disease modification (D) | null | 2017-01-04 | Carboplatin + Pemetrexed | N | N | 230001605 | OXALIPLATIN + MDG |
| 230001657 | 230001342 | 1.73 | 59.6 | Palliative (P) | 2018-04-07 | 2018-04-15 | IVA | N | null | 230001759 | ABIRATERONE |
| 230001658 | 230000786 | null | 73.5 | Palliative (P) | 2012-12-29 | 2013-05-05 | EOX | 02 | N | 230002469 | BEVACIZUMAB + FLUOROURACIL |
| 230001659 | 230000790 | 1.68 | 82.8 | Curative (C) | 2015-11-26 | 2015-12-04 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 230002610 | RITUXIMAB |
| 230001660 | 230000792 | 1.8 | 87.2 | Adjuvant (A) | null | 2019-10-17 | Capecitabine + Oxaliplatin 14day | N | N | 230002628 | CAPECITABINE |
| 230001661 | 230000797 | 1.67 | null | Palliative (P) | 2016-12-22 | 2017-01-04 | CRIZOTINIB | N | N | 230002716 | CAPECITABINE + OXALIPLATIN |
| 230001662 | 230000798 | 1.65 | 85.9 | Palliative (P) | 2019-10-13 | 2019-10-16 | Capecitabine | N | Y | 230002744 | CETUXIMAB |
| 230001663 | 230000801 | 1.65 | 83.3 | Palliative (P) | 2017-10-08 | 2018-08-24 | Trastuzumab Subcutaneous | N | N | 230002819 | OXALIPLATIN + MDG |
| 230001664 | 230000818 | 1.7 | 74.8 | Adjuvant (A) | 2017-10-20 | 2019-09-12 | FLUOROURACIL | N | N | 230003846 | CAPECITABINE + RT |
| 230001665 | 230000821 | 1.82 | 84 | Adjuvant (A) | 2018-06-03 | 2018-07-04 | Oxaliplatin + Modified de Gramont | null | null | 230003903 | CHOP R |
| 230001666 | 230000829 | 1.73 | 69 | Adjuvant (A) | 2018-09-21 | 2018-10-18 | Oxaliplatin + Modified de Gramont | 2 | N | 230004137 | DOCETAXEL |
| 230001667 | 230000833 | null | 67.2 | Palliative (P) | 2017-01-31 | 2017-01-31 | Sorafenib | 2 | N | 230004550 | BENDAMUSTINE + RITUXIMAB |
| 230001668 | 230000836 | 1.64 | 50.9 | Palliative (P) | 2019-02-16 | 2019-02-16 | Trial Unspecified | 2 | null | 230004650 | METHOTREXATE HIGH DOSE |
| 230001669 | 230000845 | 1.7 | 102 | Curative (C) | 2016-01-01 | 2016-01-19 | Fluorouracil 96hr infusion+R(4g/m2) | N | N | 230005256 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 230001670 | 230000853 | null | 84 | Palliative (P) | 2018-11-05 | 2018-11-05 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 230005457 | SORAFENIB |
| 230001671 | 230000858 | 1.74 | 0 | Palliative (P) | 2019-02-14 | 2019-02-28 | Fluorouracil 96hr infusion+R(4g/m2) | 02 | N | 230005517 | DOCETAXEL + TRASTUZUMAB |